These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 15788701)

  • 1. Prenatal exposure to the CB1 receptor agonist WIN 55,212-2 causes learning disruption associated with impaired cortical NMDA receptor function and emotional reactivity changes in rat offspring.
    Antonelli T; Tomasini MC; Tattoli M; Cassano T; Tanganelli S; Finetti S; Mazzoni E; Trabace L; Steardo L; Cuomo V; Ferraro L
    Cereb Cortex; 2005 Dec; 15(12):2013-20. PubMed ID: 15788701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term effects on cortical glutamate release induced by prenatal exposure to the cannabinoid receptor agonist (R)-(+)-[2,3-dihydro-5-methyl-3-(4-morpholinyl-methyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphthalenylmethanone: an in vivo microdialysis study in the awake rat.
    Antonelli T; Tanganelli S; Tomasini MC; Finetti S; Trabace L; Steardo L; Sabino V; Carratu MR; Cuomo V; Ferraro L
    Neuroscience; 2004; 124(2):367-75. PubMed ID: 14980386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prenatal exposure to the cannabinoid receptor agonist WIN 55,212-2 and carbon monoxide reduces extracellular glutamate levels in primary rat cerebral cortex cell cultures.
    Antonelli T; Tomasini MC; Tattoli M; Cassano T; Finetti S; Mazzoni E; Trabace L; Carratù MR; Cuomo V; Tanganelli S; Ferraro L
    Neurochem Int; 2006 Nov; 49(6):568-76. PubMed ID: 16777266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal exposure to a cannabinoid agonist produces memory deficits linked to dysfunction in hippocampal long-term potentiation and glutamate release.
    Mereu G; Fà M; Ferraro L; Cagiano R; Antonelli T; Tattoli M; Ghiglieri V; Tanganelli S; Gessa GL; Cuomo V
    Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4915-20. PubMed ID: 12679519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysregulation of the endogenous cannabinoid system in adult rats prenatally treated with the cannabinoid agonist WIN 55,212-2.
    Castelli MP; Paola Piras A; D'Agostino A; Pibiri F; Perra S; Gessa GL; Maccarrone M; Pistis M
    Eur J Pharmacol; 2007 Nov; 573(1-3):11-9. PubMed ID: 17644084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term reduction of brain-derived neurotrophic factor levels and signaling impairment following prenatal treatment with the cannabinoid receptor 1 receptor agonist (R)-(+)-[2,3-dihydro-5-methyl-3-(4-morpholinyl-methyl) pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1- naphthalenylmethanone.
    Maj PF; Collu M; Fadda P; Cattaneo A; Racagni G; Riva MA
    Eur J Neurosci; 2007 Jun; 25(11):3305-11. PubMed ID: 17552998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal exposure to the CB1 cannabinoid agonist WIN 55212-2 produces robust changes in motor function and intrinsic electrophysiological properties of cerebellar Purkinje neurons in rat offspring.
    Shabani M; Hosseinmardi N; Haghani M; Shaibani V; Janahmadi M
    Neuroscience; 2011 Jan; 172():139-52. PubMed ID: 20969930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of prenatal exposure to the CB-1 receptor agonist WIN 55212-2 or CO on the GABAergic neuronal systems of rat cerebellar cortex.
    Benagiano V; Lorusso L; Flace P; Girolamo F; Rizzi A; Sabatini R; Auteri P; Bosco L; Cagiano R; Ambrosi G
    Neuroscience; 2007 Nov; 149(3):592-601. PubMed ID: 17916407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal exposure to the cannabinoid receptor agonist WIN 55,212-2 increases glutamate uptake through overexpression of GLT1 and EAAC1 glutamate transporter subtypes in rat frontal cerebral cortex.
    Castaldo P; Magi S; Gaetani S; Cassano T; Ferraro L; Antonelli T; Amoroso S; Cuomo V
    Neuropharmacology; 2007 Sep; 53(3):369-78. PubMed ID: 17631920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal exposure to the CB1 and CB2 cannabinoid receptor agonist WIN 55,212-2 alters migration of early-born glutamatergic neurons and GABAergic interneurons in the rat cerebral cortex.
    Saez TM; Aronne MP; Caltana L; Brusco AH
    J Neurochem; 2014 May; 129(4):637-48. PubMed ID: 24329778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoid exposure in pubertal rats increases spontaneous ethanol consumption and NMDA receptor associated protein levels.
    Klugmann M; Klippenstein V; Leweke FM; Spanagel R; Schneider M
    Int J Neuropsychopharmacol; 2011 May; 14(4):505-17. PubMed ID: 21211107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex-specific behavioural deficits induced at early life by prenatal exposure to the cannabinoid receptor agonist WIN55, 212-2 depend on mGlu5 receptor signalling.
    Manduca A; Servadio M; Melancia F; Schiavi S; Manzoni OJ; Trezza V
    Br J Pharmacol; 2020 Jan; 177(2):449-463. PubMed ID: 31658362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-lasting alterations of hippocampal GABAergic neurotransmission in adult rats following perinatal Δ
    Beggiato S; Borelli AC; Tomasini MC; Morgano L; Antonelli T; Tanganelli S; Cuomo V; Ferraro L
    Neurobiol Learn Mem; 2017 Mar; 139():135-143. PubMed ID: 28104530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cannabinoid receptor agonist WIN 55,212-2 regulates glutamate transmission in rat cerebral cortex: an in vivo and in vitro study.
    Ferraro L; Tomasini MC; Gessa GL; Bebe BW; Tanganelli S; Antonelli T
    Cereb Cortex; 2001 Aug; 11(8):728-33. PubMed ID: 11459762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CB(1) cannabinoid receptors inhibit the glutamatergic component of KCl-evoked excitation of locus coeruleus neurons in rat brain slices.
    Mendiguren A; Pineda J
    Neuropharmacology; 2007 Feb; 52(2):617-25. PubMed ID: 17070872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of spontaneous neurotransmission in the nucleus of solitary tract of the rat by the cannabinoid agonist WIN 55212-2 is not via CB1 or CB2 receptors.
    Accorsi-Mendonça D; Almado CE; Dagostin AL; Machado BH; Leão RM
    Brain Res; 2008 Mar; 1200():1-9. PubMed ID: 18308297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabinoid-induced increase in relapse-like drinking is prevented by the blockade of the glycine-binding site of N-methyl-D-aspartate receptors.
    Alén F; Santos A; Moreno-Sanz G; González-Cuevas G; Giné E; Franco-Ruiz L; Navarro M; López-Moreno JA
    Neuroscience; 2009 Jan; 158(2):465-73. PubMed ID: 18977415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of N-methyl D-aspartate receptor mechanism on WIN55,212-2-induced amnesia in rat dorsal hippocampus.
    Jamali-Raeufy N; Nasehi M; Zarrindast MR
    Behav Pharmacol; 2011 Oct; 22(7):645-54. PubMed ID: 21918382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanisms of cannabinoid protection from neuronal excitotoxicity.
    Kim SH; Won SJ; Mao XO; Jin K; Greenberg DA
    Mol Pharmacol; 2006 Mar; 69(3):691-6. PubMed ID: 16299067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute exposure to methylmercury at two developmental windows: focus on neurobehavioral and neurochemical effects in rat offspring.
    Carratù MR; Borracci P; Coluccia A; Giustino A; Renna G; Tomasini MC; Raisi E; Antonelli T; Cuomo V; Mazzoni E; Ferraro L
    Neuroscience; 2006 Sep; 141(3):1619-29. PubMed ID: 16781816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.